Bristol Myers Squibb Co. news

   Watch this stock
Showing stories 1 - 10 of about 165   

Articles published

BMY 44.06 +0.30 (0.69%)
price chart
Bristol Myers Squibb Co. (BMY), Pharmacyclics, Inc. (PCYC): Hedging Against ...
Sprycel: Developed by Bristol Myers Squibb Co. (NYSE:BMY), Sprycel was approved in 2006 as a second-line treatment for patients who had Philadelphia chromosome-positive (Ph+) ALL or Ph+ CML, and had resistance to prior therapy.
Related articles »  
Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
... ratings summary and ratings history on Bristol-Myers Squibb Co. (NYSE: BMY) click here. For more ratings news on Bristol-Myers Squibb Co. click here. Shares of Bristol-Myers Squibb Co. closed at $44.34 yesterday, with a 52 week range of $30.64-$45.59.
Bristol-Myers Squibb Company (BMY) Moves Higher Ahead of ASCO Presscast ...
Shares of Bristol-Myers Squibb Company (NYSE: BMY) moved higher early on Wednesday. Abstracts for American Society of Clinical Oncology (ASCO) annual meeting are due to be released today at 6 pm, ahead of the meeting which begins on May 31st.
And The Best Bargain Is...Bristol Myers Squibb Co. (BMY), Eli Lilly & Co. (LLY ...
Bristol Myers Squibb Co. (NYSE:BMY) holds a market capitalization of $70 billion. For fiscal 2012, the company reported net sales that were 17% lower than the previous year.
Related articles »  
BRISTOL MYERS SQUIBB CO. : EmergingGrowth.com looks at Small Cap ...
The company?s product portfolio includes Tridural, Abstral and Trelstar. In February of 2011, PLB acquired the Tempra line of products in Canada from Bristol-Myers Squibb (NYSE: BMY). In November of 2011, the company garnered the rights to Travelan in ...
Related articles »  
Insider Trading Recap for Bristol Myers Squibb, Delta Air Lines, QUALCOMM ...
Bristol Myers Squibb Co. (NYSE:BMY) : By the end of last trading session, the shares of Bristol Myers Squibb (NYSE:BMY) soared US$2.13 (or 5.05%) to US$44.34 with 33.36 million shares exchanged hands, compared to daily average volume of 8.82 million ...
Bristol-Myers shares jump ahead of melanoma trial data  Reuters
Bristol-Myers edges ahead in race to develop first blockbuster PD-1 cancer drug  FierceBiotech
Related articles »  
Stocks Recap (Gran Tierra Energy Inc, Semtech Corporation, Bristol Myers ...
Gran Tierra Energy Inc. (NYSEMKT:GTE) shares jumped 5.54% and closed at $6.48 in the last trading session. The company on May 6 said its first-quarter of 2013 net income was $57.9 million, compared to a loss of $0.3 million in the comparable period in ...
BRISTOL MYERS SQUIBB CO. : Bristol-Myers Squibb to Present at Bank of ...
Bristol-Myers Squibb Company (NYSE: BMY) will present at Bank of America Merrill Lynch Health Care Conference on Wednesday, May 15, 2013, in Las Vegas.
Related articles »  
Bristol-Myers Squibb to Present at UBS Global Health Care Conference
Bristol-Myers Squibb Company (NYSE: BMY) will present at the UBS Global Health Care Conference on Tuesday, May 21, 2013, in New York City.
Related articles »  
The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, AbbVie ...
Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Bristol-Myers Squibb Company (NYSE:BMY), Sanofi (NYSE:SNY), AbbVie (NYSE:ABBV) ...
Related articles »